Health
Researchers are developing first prognostic, therapeutic epigenetic biomarker for pancreatic cancer patients – News-Medical.Net
By 2030, pancreatic ductal adenocarcinoma (PDAC), the most lethal form of pancreatic cancer, is projected to become the second leading cause of cancer-related deaths…
By 2030, pancreatic ductal adenocarcinoma (PDAC), the most lethal form of pancreatic cancer, is projected to become the second leading cause of cancer-related deaths in the United States.
Not only are therapeutic options limited, but nearly half of all PDAC patients who have their tumors removed surgically experience disease recurrence within a year, despite receiving additional chemotherapy. For more advanced stages, only about one-third of patients have a limited response to approved chemotherapy.
…
-
Noosa News5 hours agoTeenage boy crashes into Ipswich home, left fighting for life in hospital
-
General11 hours agoShored against our ruins
-
Noosa News14 hours agoCity of Moreton Bay throws homeless people’s tents into garbage trucks
-
General11 hours agoUN special envoy Julie Bishop makes first trip to Myanmar after earthquake